Observational (Non-interventional), Follow-up Trial Assessing Long-term Local Tolerability and Efficacy (Recurrence Rate) of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Observational Model: Cohort, Time Perspective: Prospective
Determine the recurrence rate of AK-lesions
Number of patients with persistent complete clearance at 6 and 12 months follow-up. Recurrence rate is to be determined at the same treatment area where the investigational medicinal products were administered in the previous trial.
at 6 and 12 months
Lars E French, MD
University Clinic of Dermatology, Zurich